Reliability of colour perimetry to assess macular pigment optical density in age-related macular degeneration

Abstract

Background:

The aim of this study was to determine the intra-session repeatability and inter-examiner reproducibility of the colour perimetry technique when assessing in vivo macular pigment optical density in age-related macular degeneration patients.

Methods:

Age-related macular degeneration patients were classified into four groups: early age-related macular degeneration, intermediate age-related macular degeneration, atrophic age-related macular degeneration and neovascular age-related macular degeneration after undergoing fundus photography (TRC 50DX type IA) and spectral-domain optical coherence tomography analysis (Topcon 3D-2000). Central fixation was confirmed in all patients using the MP-1 microperimeter (Nidek, Padua, Italy). To analyse repeatability, one examiner obtained three consecutive macular pigment optical density measures with MonCV3 device (Metrovision, Perenchies, France). To study agreement between two observers, a second examiner performed another macular pigment optical density measurement in random order. Within-subject standard deviation, coefficient of variation, and intraclass correlation coefficient data were obtained.

Results:

Fifty two (32 females and 20 males) consecutive age-related macular degeneration patients having a mean age of 71.5 ± 8.2 years were recruited. Six had early age-related macular degeneration, 25 had intermediate age-related macular degeneration, 10 had atrophic age-related macular degeneration and 11 had neovascular age-related macular degeneration. For repeatability, coefficient of variation values ranged from 22.3% (neovascular age-related macular degeneration) to 41.0% (atrophic age-related macular degeneration) and intraclass correlation coefficient values from 0.52 (intermediate age-related macular degeneration) to 0.79 (neovascular age-related macular degeneration). For agreement between two examiners, coefficient of variation values ranged from 20.1% (intermediate age-related macular degeneration) to 37.8% (neovascular age-related macular degeneration) and intraclass correlation coefficient values from 0.61 (neovascular age-related macular degeneration) to 0.80 (atrophic age-related macular degeneration).

Conclusion:

The reliability (intra-session repeatability and inter-examiner reproducibility) of colour perimetry technique to assess macular pigment optical density in age-related macular degeneration patients is only moderate. Thus, it cannot be recommended to be performed when evaluating and monitoring age-related macular degeneration patients in the daily clinic.

Keywords

Get full access to this article

View all access options for this article.

References

Wong

et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014; 2(2): e106–e116.

Ferris

3rd Wilkinson

Bird

et al. Clinical classification of age-related macular degeneration. Ophthalmology 2013; 120: 844–851.

Adrean

Chaili

Ramkumar

et al. Consistent long-term therapy of neovascular age-related macular degeneration managed by 50 or more anti-VEGF injections using a treat-extend-stop protocol. Ophthalmology 2018; 125: 1047–1053.

Buschini

Fea

Lavia

et al. Recent developments in the management of dry age-related macular degeneration. Clin Ophthalmol 2015; 9: 563–574.

Beatty

Koh

Phil

et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45: 115–134.

Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119(10): 1417–1436.

Chew

Clemons

SanGiovanni

et al. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013; 309(19): 2005–2015.

Davies

Morland

AB.

Macular pigments: their characteristics and putative role. Prog Retin Eye Res 2004; 23(5): 533–559.

Obana

Gellermann

Gohto

et al. Reliability of a two-wavelength autofluorescence technique by Heidelberg Spectralis to measure macular pigment optical density in Asian subjects. Exp Eye Res 2018; 168: 100–106.

10.

Sauer

Andersen

et al. Fluorescence lifetime imaging ophthalmoscopy (FLIO) of macular pigment. Invest Ophthalmol Vis Sci 2018; 59: 3094–3103.

11.

Dragostinoff

Werkmeister

Kaya

et al. Short- and mid-term repeatability of macular pigment optical density measurements using spectral fundus reflectance. Graefes Arch Clin Exp Ophthalmol 2012; 250(9): 1261–1266.

12.

Obana

Gohto

Tanito

et al. Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy. Graefes Arch Clin Exp Ophthalmol 2014; 252: 1221–1228.

13.

Robson

Holder

Moreland

et al. Chromatic VEP assessment of human macular pigment: comparison with minimum motion and minimum flicker profiles. Vis Neurosci 2006; 23(2): 275–283.

14.

Van der Veen

Ostendorf

Hendrikse

et al. Macular pigment optical density relates to foveal thickness. Eur J Ophthalmol 2009; 19(5): 836–841.

15.

Robson

Harding

van Kuijk

et al. Comparison of fundus autofluorescence and minimum-motion measurements of macular pigment distribution profiles derived from identical retinal areas. Perception 2005; 34(8): 1029–1034.

16.

Howells

Eperjesi

Bartlett

Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol 2011; 249(3): 315–347.

17.

Crochet

Zanlonghi

Charlier

Evaluation of macular pigment optical density with a color perimetry technique. Normal values and influence of diet. Invest Ophthalmol Vis Sci 2009; 50: 2743.

18.

Bone

Landrum

Cains

Optical density spectra of the macular pigment in vivo and in vitro. Vision Res 1992; 32(1): 105–110.

19.

Bland

Clinical measurement. In: M

Bland

(ed) An introduction to medical statistics. 3rd ed. Oxford: Oxford University Press, 2000, pp. 269–294.

20.

Bland

Altman

DG.

Measurement error and correlation coefficients. BMJ 1996; 313: 41–42.

21.

Bernstein

Vachali

et al. Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog Retin Eye Res 2016; 50: 34–66.

22.

Snodderly

Mares

Wooten

et al. Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and Age-Related Eye Disease Study. Invest Ophthalmol Vis Sci 2004; 45(2): 531–538.

23.

SanGiovanni

Chew

Clemons

et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report no. 22. Arch Ophthalmol 2007; 125(9): 1225–1232.

24.

van Leeuwen

Witteman

et al. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol 2011; 129(6): 758–766.

25.

Howells

Eperjesi

Bartlett

Improving the repeatability of heterochromatic flicker photometry for measurement of macular pigment optical density. Graefes Arch Clin Exp Ophthalmol 2013; 251(3): 871–880.

26.

Kutzko

Brito

Wall

Effect of instructions on conventional automated perimetry. Invest Ophthalmol Vis Sci 2000; 41(7): 2006–2013.

27.

Demirel

Ozmert

Batioglu

et al. A color perimetric test to evaluate macular pigment density in age-related macular degeneration. Optom Vis Sci 2016; 93(6): 632–639.

28.

Loughman

Scanlon

Nolan

et al. An evaluation of a novel instrument for measuring macular pigment optical density: the MPS 9000. Acta Ophthalmol 2012; 90(2): e90–e97.

29.

De Kinkelder

van der Veen

Verbaak

et al. Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry. Eye 2011; 25(1): 105–112.

30.

Bartlett

Stainer

Singh

et al. Clinical evaluation of the MPS 9000 macular pigment screener. Br J Ophthalmol 2010; 94(6): 753–756.

31.

Creuzot-Garcher

Koehrer

Picot

et al. Comparison of two methods to measure macular pigment optical density in healthy subjects. Invest Ophthalmol Vis Sci 2014; 55(5): 2941–2946.

32.

Broendsted

Hansen

Lund-Andersen

et al. Human lens transmission of blue light: a comparison of autofluorescence-based and direct spectral transmission determination. Ophthalmic Res 2011; 46(3): 118–124.

33.

Pfau

Lindner

Müller

et al. Effective dynamic range and retest reliability of dark-adapted two-color fundus-controlled perimetry in patients with macular diseases. Invest Ophthalmol Vis Sci 2017; 58(6): BIO158–BIO167.

34.

Connolly

Beatty

Thurnham

et al. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Curr Eye Res 2010; 35(4): 335–351.